JEM Research Institute

Medications like GLP-1R agonists, originally developed for obesity and diabetes, are now showing potential to reduce dementia risk and transform how we understand and treat conditions like Alzheimer’s and Parkinson’s.

Explore how the intersection of metabolism and neurology is rewriting the brain playbook in this blog post, written by Dr. Linda Pao, Co-Medical Director, Principal Investigator at JEM Research Institute, a Headlands Research site: https://headlandsresearch.com/blogs/the-future-of-neuro-research-metabolic-drugs-are-rewriting-the-brain-playbook/

The Future of Neuro Research: Metabolic Drugs Are Rewriting the Brain Playbook - Headlands Research Explore how metabolic drugs are rewriting the brain playbook in this blog post, written by Dr. Linda Pao, Co-Medical Director and PI at JEM Research.